Search research articles
Contact Us
Filters
Showing results (31-40 of 141) with videos related to
Page
of 15
Sort By:
Current Problems in Dermatology
|
June 26, 2013
Concept of major life-changing decisions in life course research
Zaheer U Bhatti, Sam Salek, Andrew Y Finlay
Frontiers in Pharmacology
|
March 30, 2019
The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
Andrea Keyter, Sam Salek, Shabir Banoo, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
An Evaluation of the Efficiency of the Gulf Cooperation Council's Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical Companies: Recommendations for an Improved Model
Mohamed H Al-Rubaie, Sam Salek, Stuart Walker
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 25, 2012
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe
Melike Deger, Wolfgang Eisterer, Lucie Kutikova, et al.
Frontiers in Pharmacology
|
July 7, 2020
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
Andrea Keyter, Sam Salek, Shabir Banoo, et al.
Frontiers in Pharmacology
|
July 18, 2017
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
Nicola Allen, Lawrence Liberti, Stuart R Walker, et al.
Therapeutic Innovation & Regulatory Science
|
February 20, 2020
Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
Magdalena Bujar, Neil McAuslane, Stuart R Walker, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland
Nicola Allen, Stuart R Walker, Lawrence Liberti, et al.
The Journal of Urology
|
April 19, 2014
Re: development of an instrument to assess the health related quality of life of kidney stone formers: K. L. Penniston and S. Y. Nakada J Urol 2013;189:921-930
Aditya Raja, Claire O'Neill, Hrishi B Joshi, et al.
The Patient
|
September 21, 2016
Using PROMs in Healthcare: Who Should Be in the Driving Seat-Policy Makers, Health Professionals, Methodologists or Patients?
Kirstie L Haywood, Roger Wilson, Sophie Staniszewska, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 141) with videos related to
Sort By:
Page
of 15
Current Problems in Dermatology
|
June 26, 2013
Concept of major life-changing decisions in life course research
Zaheer U Bhatti, Sam Salek, Andrew Y Finlay
Frontiers in Pharmacology
|
March 30, 2019
The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
Andrea Keyter, Sam Salek, Shabir Banoo, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
An Evaluation of the Efficiency of the Gulf Cooperation Council's Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical Companies: Recommendations for an Improved Model
Mohamed H Al-Rubaie, Sam Salek, Stuart Walker
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 25, 2012
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe
Melike Deger, Wolfgang Eisterer, Lucie Kutikova, et al.
Frontiers in Pharmacology
|
July 7, 2020
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
Andrea Keyter, Sam Salek, Shabir Banoo, et al.
Frontiers in Pharmacology
|
July 18, 2017
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
Nicola Allen, Lawrence Liberti, Stuart R Walker, et al.
Therapeutic Innovation & Regulatory Science
|
February 20, 2020
Quality Decision Making in Health Technology Assessment: Issues Facing Companies and Agencies
Magdalena Bujar, Neil McAuslane, Stuart R Walker, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland
Nicola Allen, Stuart R Walker, Lawrence Liberti, et al.
The Journal of Urology
|
April 19, 2014
Re: development of an instrument to assess the health related quality of life of kidney stone formers: K. L. Penniston and S. Y. Nakada J Urol 2013;189:921-930
Aditya Raja, Claire O'Neill, Hrishi B Joshi, et al.
The Patient
|
September 21, 2016
Using PROMs in Healthcare: Who Should Be in the Driving Seat-Policy Makers, Health Professionals, Methodologists or Patients?
Kirstie L Haywood, Roger Wilson, Sophie Staniszewska, et al.
Page
of 15